Description: The Society of Actuaries SoA developed this research project to repeat and expand upon its “Group Medical Insurance Large Claims Database Collection and Analysis” study, which was published as a monograph in August of 1997. The general purpose of these studies is to discover and analyze factors affecting claim incidence rates and the distribution of claim sizes. This is the report for the database. Please see the SOA website experience studies for Group Health for the databases themselves.

Description: This article notes the available pulications from Hank George, an underwriting expert, that will help keep you up to date on the subject.

Description: The Society of Actuaries Research Institute developed a new study to explore pharmacy financing. The goals of the SOA related to this research are to identify opportunities to increase transparency, encourage competition, align stakeholder incentives and mitigate increases in total cost of care. The research uses a value-based methodology.

Description: Learn how insurers provide new opportunities for efficiency and value creation from product design and underwriting through customer engagement and claims. Glimpse some industry use cases for Gen AI and its outcomes as observed by the first movers.

Description: Connect with the health actuarial community -- explore innovative solutions, advance your career, and participate in engaging, interactive events. Join the industry’s leading actuaries, analysts and professionals to network and discuss the impacts of the latest marketplace factors and trends.

Description: The Candidate Connect at the 2024 Health Meeting provides information, inspiration and networking opportunities to actuarial candidates pursuing their ASA.

Description: Article reviews the data a year into the unwinding of continuous coverage provisions in Medicaid, the impact on enrollment counts, how capitation rates have been adjusted, and compares those results to what has been modeled with the SOA Mediciad Unwinding model.

Description: There is a big wave of changes coming to the pharmacy market. The extent is not yet fully known, but there are trends we can follow that help us predict. Biosimilar uptake is key to driving savings, but it can take a while to ramp up. Biosimilars bring competition, and this coming wave will bring unprecedented Biosimilar competition.

Description: Session 1E: ACA Pricing for 2026 and 2027 - Navigating the Federal Changes

Description: Session 3D: HIV + Medicare - Past, Present, and an Equitable Future